Form 4: UPEXI Director Acquires 25,000 Stock Options
SEC Form 4 Filing
Lawrence Dugan, a director of UPEXI, Inc. (UPXI), acquired 25,000 options to buy common stock on January 17, 2025.
Summary
- On January 17, 2025, Lawrence Dugan, a director of UPEXI, Inc., acquired 25,000 options to buy common stock.
- The exercise price of these options is $3.46.
- The options become exercisable on April 17, 2025, and expire on January 17, 2035.
- Following this transaction, Mr. Dugan directly owns 25,000 derivative securities.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of an insider transaction. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company directors.
Stakeholder Impact
- The acquisition of options by a director could be perceived positively by shareholders as it aligns the director's interests with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 01/17/2025 | Date of transaction: Lawrence Dugan acquired 25,000 options to buy common stock. |
| 04/17/2025 | Options become exercisable. |
| 01/17/2035 | Options expiration date. |
| 04/24/2025 | Date of signature for the Form 4 filing. |
Keywords
Form 4, UPEXI, UPXI, Director, Stock Options, Lawrence Dugan, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.